Ascofuranone (AF) (Fig. 1A) , was originally isolated as an antiviral and antifungal compound possessing a unique prenylphenol moiety.
Ascofuranone (AF) (Fig. 1A) , was originally isolated as an antiviral and antifungal compound possessing a unique prenylphenol moiety. 1) AF has also been shown to have significant anti-tumor activity against various transplantable tumors and was able to suppress metastasis of a melanoma and a lung carcinoma in murine experimental models.
2) It is generally assumed that the antitumor activity of AF is mediated by the activation of a host defense mechanism against tumors, since pretreatment with AF prior to tumor implantation is as effective as AF treatment after tumor inoculation. AF activates macrophages, thus enhancing IL-1 production and cytotoxic activity against syngeneic tumor cells. It also suppresses lymphocyte functions including IL-2 production and natural killer activity in vitro.
3) Intraperitoneal injection of AF activates phagocytic activity as evidenced by carbon clearance tests, natural killer activity in the spleen, and enhanced tumorigenetic activity of macrophages and neutrophiles in the peritoneal cavity, whereas conversely, inactivation of peritoneal phagocytes by silica injection caused almost complete abolition of AF's prophylactic anti-tumor activity. 2) Osteosarcoma is the most common type of bone cancer and is the sixth most common type of cancer in children. Osteosarcomas develop most commonly near the ends of the long bones, especially around the knees. In children and adolescents, about 80% of osteosarcomas develop in the bones around the knee. The first choice of treatment for osteosarcoma is neoadjuvant chemotherapy. Multiple anticancer drugs such as methotrexate, doxorubicin, cisplatin, etoposide, and cyclophosphamide are commonly used, either alone or in combination. 4) Although adjuvant chemotherapy is effective in improving patient survival and the treatment of the primary tumor, 5) some groups of patients who present with metastatic disease and patients with tumors that recur after treatment continue to have a poor prognosis. In addition, the frequent acquisition of drug-resistant phenotypes and the occurrence of "second malignancy", which are often associated with chemotherapy, remain as serious problems. Therefore, there is a clear need for newer and effective agents for patients with osteosarcoma, especially for patients who present with metastatic disease or who develop disease recurrence.
Recently, the proteomic approach is considered as the key technology in the global analysis of protein expression and in the understanding of gene function in the post-genomic era. Two-dimensional electrophoresis (2-DE) is also one of the best experimental tools for reliable separation of thousands of proteins in a single gel by isoelectric point and molecular mass. 6) Using Coomassie blue staining, protein spots on the gel can be visualized and differences in protein levels determined by appropriate 2-D analysis software. Digested proteins of interest can then be identified by matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry. This combination of techniques makes it possible to study patterns of change in the levels of numerous proteins. Studies can be facilitated by comparing the gel patterns obtained from cells under different treatment conditions, with the 2-DE reference gels representing the typical pattern of the cells studied under normal conditions.
The objective, then, of the present work was to assess the anti-tumor effects of AF on U2OS cells and clearly to elucidate the molecular mechanisms underlying anti-tumor activity of AF on U2OS cells with AF. This is why we started with the U2OS cells reference map then compared it with gels made using U2OS cells treated with AF. In the present report, the association of 2-DE with MALDI-TOF mass spectrometry and database interrogations allowed us to identify 38 proteins differentially expressed in U2OS cells following AF treatment.
MATERALS AND METHODS
Cell Culture and Biological Reagents U2OS osteosarcoma cells, Hep-G2 hepatoma cells, and THP-1 human monocyte cells were obtained from the American Type Culture Collection (Manassas, VA, U.S.A.). Cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Gland Island, U.S.A.) containing 10% fetal bovine serum, 20 mM HEPES buffer, and 100 mg/ml gentamicin. The cells were maintained at 37°C. AF produced by Ascochyta viciae was purified as described previously.
7)
Cytotoxicity Assays Reduction of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Roche Applied Science) assay was performed, as described in the manufacturer's protocol, to evaluate the cytotoxicity of AF.
Protein Extraction U2OS cells were washed three times with ice-cold PBS. Cells were lysed with a buffer containing 5 mM EDTA, 9.5 M urea, 4% (v/v) CHAPS, 65 mM DTT, and protease inhibitors (Complete kit, Roche Diagnostics, Germany) at 24°C over 1 h. Cellular debris was removed by centrifugation at 20000ϫg at 4°C for 15 min. Protein samples were stored at Ϫ70°C. Protein concentrations were quantified using the Amersham Biosciences PlusOne 2-D Quant Kit (Uppsala, Sweden). In some cases, U2OS cells were treated with AF for 12 h. Two-Dimensional Gel Electrophoresis Protein samples were mixed with loading buffer for the IPG strips. The mixture was applied to dry 170 mm immobilized pH 3-10 linear gradient strips (ReadyStrip IPG strip, Bio-Rad) in a PRO-TEAN IEF cell (Bio-Rad). Complete sample uptake into the strips was achieved after 12 h at 20°C. Focusing was performed according to the method of Kang et al. 8) After, these strips were reduced (1% dithioerythritol) then alkylated (2.5% iodoacetamide) in equilibration buffer (6 M urea, 50 mM Tris-HCl, pH 6.8, 30% glycerol, 2% SDS). Electrophoresis was carried out using a SE600 system (Amersham Pharmacia), with 25 mM Tris, 192 mM glycine, and 0.1% w/v SDS as the running buffer, at 20°C at 120 V per gel for 8 h, or until the bromophenol blue had reached the bottom of the gel. Data shown are means of three independent experiments. For the differential analysis, statistical significance was estimated with Student's t-test. p values Ͻ0.05 were considered significant.
Staining of 2-DE Gels and 2-D Image Analysis Coomassie blue staining was performed according to the method of Neuhoff et al. 9) The staining patterns on the 2-D gels were digitized at 300 dpi resolution using a UMAX PowerLook 1120 (UMAX Technologies, Inc., Dallas, U.S.A.) scanner. The scans were exported in TIFF format and imported into PDQUEST (Bio-Rad) image analysis software for analysis. Briefly, after automatic spot detection, the background was removed from each gel and the images were edited manually, i.e., adding, splitting, and removing spots. One gel was chosen as the master gel and used for automatic matching of spots in the other 2-DE gels.
MALDI-TOF MS and Database Search
Identification of the protein spots was performed according to the method of Kang et al. 8, 10) MALDI-TOF MS analyses were performed on a Voyager DE-STR MALDI-TOF mass spectrometer (Applied Biosystems, Foster City, CA, U.S.A.). Trypsin-digested samples (0.5 ml) were mixed with 0.5 ml of matrix solution (10 mg/ml a-cyano-4-hydroxycinnamic acid in 50% acetonitrile/0.1% TFA) and the mixed solution was spotted onto a 96-spot MALDI target. The MALDI-TOF mass spectrometer was operated in positive-ion, delayed-extraction (200 ns delay time) reflector mode. Results were analyzed with Data Explorer software (Applied Biosystems) to obtain accurate masses for all peptides in the tryptic digest. Protein identification was performed as described. Taxonomy was set to human, and MS-Fit high scores were caculated at Յ30 mass peaks with the highest signal intensity; trypsin and keratin peaks were excluded. The resulting peptide mass fingerprints, together with the pI and MW values (estimated from the 2-DE gels), were used to search the Swiss-Prot or NCBInr protein databases with a special search tool [MS-FIT from Protein Prospector V 4.27.1 (http://169.230.19.26: 8080/prospector/4.27.1)], which compares the experimentally determined tryptic peptide masses with theoretical peptide masses calculated for proteins contained in the SwissProt or NCBInr protein databases. Search parameters were Ϯ50-150 ppm peptide mass tolerance and one maximum missed cleavage.
Western Blot Analysis Total protein extracts were prepared as previously described.
11) Matrix metalloproteinase-2 (MMP-2) was assessed by Western blot analysis. Briefly, 20-50 mg of protein extracts were run on 10% SDS-PAGE gels, transferred, and incubated with an anti-MMP-2-specific polyclonal antibody (Santa Cruz; 1 : 1000), followed by a human anti-rabbit-specific antibody (1 : 1000) (Amersham Pharmacia) and developed using enhanced chemiluminescent detection methods (ECL Kit, Amersham Pharmacia Biotech, U.K.).
Gelatin Substrate Gel Zymography The matrix-degrading activity of MMP-2 was assayed by zymography, which was performed using a previously described procedure with minor modifications.
11) Gels were stained with Coomassie Brilliant Blue R-250 (Bio-Rad) for 1 h and destained. Proteolytic activity was evidenced as clear bands against the blue background of the stained gelatin.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) After treatment of cells with AF, total RNA was isolated from treated and untreated cells using TRIzol reagent (Sigma), according to the manufacturer's instructions. RNA yield and purity were assessed by spectrophotometric analysis. Total RNA (10 mg) from each sample was subjected to reverse transcription with random hexamers, dNTPs, and M-MLV reverse transcriptase (Promega) in a 20 ml total reaction volume. PCR of cDNA was performed using specific primers for the protein of interest. PCR products were resolved electrophoretically on 1.0% agarose gels, and DNA bands visualized by staining the gel with ethidium bromide. The expression of measured genes in each sample was normalized to b-actin expression. All samples were analyzed in triplicate. The primers were: MMP-2 sense: 5Ј-GGC CCT GTC ACT CCT GAG AT-3Ј, MMP-2 antisense: 5Ј-GGC ATC CAG GTT ATC GGG GA-3Ј, EPCR-sense: 5Ј-CAA TGC CTA CAA CCG CAC TCG-3Ј, EPCR-antisense: 5Ј-CAG GAA GAT GCC TAC AGC CAC AC-3Ј, b-actin sense: 5Ј-GCC ATC GTC ACC AAC TGG GAC-3Ј, b-actin antisense: 5Ј-CGA TTT CCC GCT CGG CCG TGG-3Ј.
RESULTS AND DICUSSION

Cytotoxicity of AF on Several Cell Lines
Since AF is known to have antibiotic activity, we first tested the cytotoxic effects of AF on U2OS in serum-free and 10% serum-containing medium using an MTT assay. Treatment of cells with AF ranging from 1 to 50 mM showed a 5-10% decrease in cell viability in serum-free medium (Fig. 1B) . Also we showed cytotoxicity of AF on hepatoma cell line (Hep-G2) and human monocyte cell line (THP-1). As shown in Fig. 1B , we showed similar results as U2OS cells.
Comparison of Protein Expression Profiles in AFTreated and, -Untreated U2OS Cells To investigate the effect of AF on protein expression, U2OS cells were incubated with and without AF treatment for 12 h. Proteomic analysis of whole cell extracts from U2OS cells incubated with and without AF treatment were performed by 2-DE. Gels of three different samples with the same treatment were performed simultaneously and analyzed by PDQuest Image Analysis Software. In total, 1000Ϯ87 spots were detected on the maps. The overall protein expression profiles with pI 3-10, pI 4-7 and molecular mass of 10-130 kDa were very similar between the three samples within the same group analyzed by PDQuest software, indicating a high stability and reproducibility of the 2-DE in our test system. Figure 2 shows a pair of representative 2-DE gel images of expression profiles with pI 3-10, pI 4-7 in U2OS cells. The densities of the spots were determined with normalization based on total spots volumes on the gel. Protein spots with significant changes in densities in a consistent direction (increase or decrease) were judged as deregulated and were cut out for identification. Thirty-eight differential spots were found, of which 18 were up-regulated and 20 were down-regulated.
Identification of Differentially Expressed Proteins by MS Protein spots from the 2-D gel were subjected to trypsin digestion and MALDI-TOF analysis (Fig. 2D) . At least 70 spots were differentially expressed and 38 proteins were successfully identified. Table 1 lists the most strongly differentially expressed proteins, which were up-or downregulated more than two-fold by AF treatment. More than 95% of spots had a sequence coverage exceeding 10%. Identification was validated by agreement between the apparent MW and pI determined from 2-D gels and the theoretical values of the identified proteins (DMWϽ20% or DpIϽ0.5).
Furthermore, the differentially expressed proteins identified were classified in functional categories and localization cartegories. As shown in Fig. 3 , most differentially expression proteins are involved in energy metabolism (glycolysis, 5%; metabolism, 11%) and RNA processing (17%). Also, most of these proteins were situated:cytoplasm (36%) and nucleus (13%).
Various proteins involved in the regulation of several metabolic pathways were identified. The typical metabolic capabilities of U2OS cells were illustrated by the identification of several metabolic enzymes, i.e., hydroxyindole methyltransferase, pyruvate kinase isozymes, glutathione Stransferase Mu, fructose-bisphosphate aldolase C, pyruvate dehydrogenase, and indoleamine 2,3-dioxygenase.
In this study, MMP-2 was detected in U2OS cells treated with AF. MMPs are a group of zinc-dependent endopeptidases involved in the process of tissue remodeling through degradation of the extracellular matrix (ECM). Tissue remodeling occurs in various physiologic conditions, such as embryogenesis and wound healing, as well as in pathologic conditions, including inflammatory diseases, tumor cell invasion, and angiogenesis. 12) Most MMPs are secreted as inactive proproteins, which are activated when cleaved by extracellular proteinases. In addition, MMPs are regulated at multiple levels including transcription, secretion, and activation of inactive zymogens, while their tissue activity is under the strict control of specific inhibitors, i.e., tissue inhibitors of metalloproteinases. 13) These enzymes play a role in menstrual endometrial breakdown, regulation of vascularization, and the inflammatory response. Among the MMPs, MMP-2 (gelatinase A: pro-enzyme, 72 kDa, constitutive) is of particular interest because of its novel roles other than tissue remodeling. Recently, MMP-2 has been found to play a role in acute disease processes such as platelet aggregation, 14) the regulation of vascular tone, 15) and myocardial dysfunction after ischemia-reperfusion. 16) In this study, MMP-2 expression was significantly decreased by AF treatment.
Also, we showed that urokinase receptor (u-PAR) expression was reduced by AF treatment. This protein is a 55-60 kDa heavily glycosylated, disulfide-linked cell surface receptor that, together with its ligand u-PA, leads to a very efficient plasmin-mediated degradation of extracellular matrix components such as fibrin and collagen IV. 17) It is therefore one of the molecules promoting invasion and metastasis that has repeatedly been shown to be predictive of poor clinical prognosis for a diverse set of carcinomas. 18) In addition, sev- eral studies have shown an over-expression of the u-PAR gene in human tumor. 19) In the present study, u-PAR expression was significantly reduced by AF treatment.
Generally, endothelial cell protein C receptor (EPCR) may play a modulatory role in vascular responses to inflammation, stress or injury. 20) EPCR is a type 1 transmembrane glycoprotein containing two domains in the extracellular region that are homologous to the a1 and a2 domains of CD1/MHC class I molecules. 21, 22) In human tissues, the protein was found to be present almost exclusively in endothelial cells of large blood vessels. 23) However, EPCR is not only expressed on endothelial cells but can also be found in several cell lines derived from various types of cancer. In this study, we showed that EPCR expression can be reduced by AF treatment.
Moreover, 17% of proteins involved in RNA processing were affected by AF treatment. For example, protein involved in pre-mRNA splicing (heterogeneous nuclear ribonucleoprotein L) was found to be modulated by AF as well. These data suggest that AF can play a role in mRNA maturation and export.
Confirmation of Differentially Expressed Proteins
To confirm some of the changes in protein expression and gene expression after AF treatment, we performed western blot analysis for the differentially expressed protein MMP-2. In addition, we measured the change in MMP-2 activity by zymography and the MMP-2 genes and EPCR genes by RT-PCR analysis.
Western Blot Analysis and Zymography From the protein list given in Table 1 , MMP-2 was selected for confirmation experiments using Western blot analysis. As shown in Fig. 4A , MMP-2 expression was reduced in AF-treated U2OS cells, and zymography demonstrated that the extracts from the culture medium contained low amounts of the activated form of MMP-2. As shown in Fig. 4B , treatment with AF decreased MMP-2 activity. In addition, MMP-2 expression and activity were decreased in a dose-dependent manner (Fig. 4C) . Therefore the Western blot and zymography results confirmed the changes observed by proteomic analysis.
Validation of Selected Proteins by RT-PCR Analysis
Further to validate the proteomic data, we also performed quantitative RT-PCR analysis of MMP-2 gene and EPCR gene. Figure 5 shows the mRNA expression patterns of the genes for MMP-2. MMP-2 mRNA was significantly decreased (2.5-fold) in AF-treated cells compared with control cells. Also, EPCR mRNA was significantly decreased (2.5- In summary, various antiviral compounds have been isolated from the phytopathogenic fungus A. viciae. 1) Among the various prenyl-phenol compounds, AF is a potent antiviral and antifungal compound. Its derivatives are known to modulate a variety of physiological activities and have demonstrated a variety of antitumor, antimetastatic, and antidiabetic activities in animals. However, the molecular mechanisms for these physiological effects are unclear.
Therefore we applied 2-D gel electrophoresis and the identification of proteins by mass spectrometry to analyze the proteome of human osteosarcoma cells treated with AF. With this technique, we identified 38 proteins whose expression consistently changed with AF treatment. Most of the proteins that were down-regulated in U2OS cells treated with AF were those associated with tumor growth, such as MMP-2 and endothelial protein C receptor. Also, we demonstrate that AF inhibits invasion of osteosarcoma cells by inhibiting expression of MMP-2. Our results suggest that AF may be use- a) Protein names and functions have been assigned according to PubMed and Swiss-Prot/TrEMBL. The table shows the differentially expressed proteins (ratio Ն2) that were up-or down-regulated (Ϫ) in response to ascofuranone treatment for 12 h. The fold change columns correspond to the expression of each protein relative to its expression in control cells. Results are means of three independent experiments performed for each condition. The spot numbers are identical to those given in Fig. 2 . In conclusion, more in-depth studies should be done to increase our understanding of the mechanisms by which AF affects cells and its potential as a chemotherapeutic agent against cancer cells. 
